Related Experiment Videos
The endothelin system in human glioblastoma
G Egidy1, L P Eberl, O Valdenaire
1INSERM U36, Collège de France, Paris.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|November 25, 2000
Summary
Endothelin-1 (ET-1) from glioblastoma vasculature acts as an anti-apoptotic factor via ET(B) receptors on cancer cells, not a proliferation factor. Targeting this pathway with bosentan induces glioblastoma cell death.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Endothelin-1 (ET-1) is a peptide implicated in cancer cell proliferation and survival.
- The endothelin system's role in glioblastoma, a highly aggressive brain tumor, requires further elucidation.
Purpose of the Study:
- To investigate the expression and function of the endothelin system components in human glioblastoma.
- To determine if ET-1 acts as a survival or proliferation factor in glioblastoma cells.
Main Methods:
- Immunohistochemistry and mRNA analysis of endothelin system components (preproendothelin-1, ECE-1, ET(A) and ET(B) receptors) in glioblastoma tissues and cell lines.
- Treatment of glioblastoma cell lines with bosentan (ET receptor antagonist) and Fas Ligand, assessing apoptosis and signaling pathways (PKC, ERK, FLIP).
Main Results:
- Endothelin system components were differentially expressed in glioblastoma vasculature and cells, with ET(B) receptors predominantly on cancer cells.
- Bosentan induced apoptosis in glioblastoma cell lines, potentiated by Fas Ligand in cells expressing functional Fas and short FLIP.
- ET-1 promoted transient ERK phosphorylation but not proliferation, suggesting an anti-apoptotic role involving PKC and FLIP stabilization.
Conclusions:
- Glioblastoma vasculature produces ET-1, which acts primarily as an anti-apoptotic survival factor on cancer cells via the ET(B) receptor.
- The endothelin system represents a potential therapeutic target for glioblastoma, with bosentan demonstrating pro-apoptotic effects.